Captrust Financial Advisors

SEC CIK: 0001512024
Latest filing: Aug 13, 2026

SEC filings (opens in a new tab)

ZYNE holding history

Zynerba Pharmaceuticals, Inc. in every 13F filed by Captrust Financial Advisors, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ZYNE overview All 13F holders of ZYNE Full Q2 2026 holdings

Shares (Q4 2021): 0; Sold out in Q4 2021
Value: $0
% of portfolio: 0.0%
Quarters held: 3; Since Q1 2021

Holdings of ZYNE by Captrust Financial Advisors, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q4 2021	0	$0	0.0%	−100−100.0%	Sold out	Holders
Q3 2021	100	$0	0.0%	00.0%	Unchanged	Holders
Q2 2021	100	$1.00K	<0.1%	00.0%	Unchanged	Holders
Q1 2021	100	$0	0.0%	–	–	Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.